In summary, we have shown here that the FGFR4-388Arg variant has an impact on the tumorigenic behavior of lung cancer cell lines by inducing an EMT expression profile through increased N-cadherin expression and overactivation of MAPK and AKT signaling. The gene discussed is CDH2; the disease is lung cancer.